Objective: To compare the incidence of parenteral nutrition-associated cholestasis (PNAC) between two pediatric parenteral amino-acid formulations, Aminosyn PF (APF) and Trophamine (TA).
Setting: Tertiary newborn intensive-care nursery.
Subjects: A total of 661 neonates who received either TA or APF.